Medicine
September 1, 2026 · via Europe PMC
Effect of a short questionnaire (7VTE-Quest) on venous thromboembolism to guide education during consultation.
Sarger T, Desmurs-Clavel H, Melin-Boucetta I, Dargaud Y, Catella J.
AI summary — for doctors, generated from the abstract only
A short patient questionnaire used to guide education during anticoagulation consultations was associated with improved patient knowledge scores over time for most patients, though some specific knowledge areas (notably NSAID-anticoagulant interaction) showed regression, and clinical outcome impact was not assessed.
What was studied
A single-clinic study of 135 patients on anticoagulant therapy (≥3 months) who completed a short venous thromboembolism knowledge questionnaire (7VTE-Quest) at two consultations (March 2022-December 2024, mean 211 ±169 days apart), used to guide patient education, with the primary endpoint being an improved score (≥1 point) at the second completion.
Key findings
- After excluding 4 patients with perfect scores at both time points, knowledge scores improved for 56.5% (74/131) of patients, with total score change ranging from -3 to +4.
- The greatest knowledge gains were for forgotten medication dose management (20.0%, 27/135) and anticoagulant-NSAID interaction (11.1%, 15/135).
- A regression in correct answers was observed across all questions (1.6%-40%), with the largest regression for NSAID contraindication knowledge: 40.0% (14/35) who initially knew it could no longer recall it, though 29.0% (29/100) who initially didn't know it learned it by the second visit.
Clinical relevance
This may be relevant to clinics managing anticoagulated patients, suggesting a brief, repeatable questionnaire-guided education strategy can improve certain knowledge gaps over time, though the authors explicitly note the study did not assess whether this translated into improved clinical outcomes (e.g., bleeding or recurrent VTE rates).
Who should care
Limitations
Single-clinic, uncontrolled study design without a comparison group receiving standard education alone; the authors explicitly state the study failed to assess impact on clinical outcomes; knowledge regression in some areas suggests the educational effect may not be durable.
A short, repeated knowledge questionnaire used to guide anticoagulation education improved patient knowledge for most patients, but some learned information was later forgotten, and the approach's effect on actual clinical outcomes remains unknown.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Anticoagulation treatment of venous thromboembolism (VTE) carries potential risks, including major bleeding and recurrent VTE, often due to poor adherence, which is itself associated with insufficient patient knowledge. To investigate patient knowledge over time to evaluate the effectiveness of the strategy of patient education employed in our clinic. We created a short patient questionnaire (7VTE-Quest), completed in the waiting room and used to guide patient education during consultation. Patients requiring anticoagulant therapy ≥3 months and having completed the 7VTE-Quest at 2 different consultations between March 2022 and December 2024 were included. The primary endpoint was improved score (≥1 point) at second completion of the questionnaire. A total of 135 patients completed the questionnaire a second time a mean (±SD) 211 (±169) days after the initial completion. After excluding 4 patients who achieved a perfect score both times, the score improved for 56.5% (74/131) of patients. The change in total score ranged from -3 to +4. The greatest overall gain was for questions on management of forgotten medication dose (20.0%, 27/135) and interaction between anticoagulants and NSAIDs (11.1%, 15/135). A regression in the number of patients providing correct answers was observed for all questions between 1.6 and 40%. The greatest regression was observed for NSAID contraindication: 40.0% (14/35) of patients could no longer recall this contraindication, while 29.0% (29/100) of those who could not initially recall this contraindication did so at the second completion. The strategy we propose shows an improvement of patient knowledge on their VTE disease and treatment but failed to assess its impact on clinical outcomes.
DOI
10.1097/md.0000000000050491
PMID
42760734
PMCID
PMC13593030
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed